Literature DB >> 18294478

An exploratory prospective study of marijuana use and mortality following acute myocardial infarction.

Kenneth J Mukamal1, Malcolm Maclure, James E Muller, Murray A Mittleman.   

Abstract

BACKGROUND: The relationship of marijuana use with coronary heart disease, including prognosis among patients with coronary heart disease, is uncertain.
METHODS: We conducted an inception cohort study of 1913 adults hospitalized with myocardial infarction at 45 US hospitals between 1989 and 1994, with a median follow-up of 3.8 years. We ascertained total mortality according to self-reported marijuana use in the preceding year.
RESULTS: A total of 52 patients reported marijuana use during the prior year, and 317 patients died during follow-up. Compared with nonuse, marijuana use less than weekly was associated with a hazard ratio of 2.5 (95% CI, 0.9-7.3). The corresponding hazard ratio for weekly use or more was 4.2 (95% CI, 1.2-14.3). The age- and sex-adjusted hazard ratios associated with any use were 1.9 (95% CI, 0.6-6.3) for cardiovascular mortality and 4.9 (95% CI, 1.6-14.7) for noncardiovascular mortality. In a comparison of 42 marijuana users and 42 other patients matched on propensity scores, there were 6 deaths among marijuana users and one among non-users (log-rank P = .06).
CONCLUSIONS: These preliminary results suggest possible hazards of marijuana for patients who survive acute myocardial infarction. Although marijuana use has not been associated with mortality in other populations, it may pose particular risk for susceptible individuals with coronary heart disease.

Entities:  

Mesh:

Year:  2008        PMID: 18294478      PMCID: PMC2276621          DOI: 10.1016/j.ahj.2007.10.049

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  37 in total

1.  Occupational attainment, smoking, alcohol intake, and marijuana use: ethnic-gender differences in the CARDIA study.

Authors:  B L Braun; P Hannan; M Wolfson; R Jones-Webb; S Sidney
Journal:  Addict Behav       Date:  2000 May-Jun       Impact factor: 3.913

2.  Evaluation of sex-related differences in survival after hospitalization for acute myocardial infarction.

Authors:  K J Mukamal; J E Muller; M Maclure; J B Sherwood; M A Mittleman
Journal:  Am J Cardiol       Date:  2001-10-01       Impact factor: 2.778

Review 3.  Cognitive measures in long-term cannabis users.

Authors:  Harrison G Pope; Amanda J Gruber; James I Hudson; Marilyn A Huestis; Deborah Yurgelun-Todd
Journal:  J Clin Pharmacol       Date:  2002-11       Impact factor: 3.126

Review 4.  Cardiovascular consequences of marijuana use.

Authors:  Stephen Sidney
Journal:  J Clin Pharmacol       Date:  2002-11       Impact factor: 3.126

5.  Marijuana use and injury events resulting in hospitalization.

Authors:  Susan Goodwin Gerberich; Stephen Sidney; Barbara L Braun; Irene S Tekawa; Kimberly K Tolan; Charles P Quesenberry
Journal:  Ann Epidemiol       Date:  2003-04       Impact factor: 3.797

6.  Prior alcohol consumption and mortality following acute myocardial infarction.

Authors:  K J Mukamal; M Maclure; J E Muller; J B Sherwood; M A Mittleman
Journal:  JAMA       Date:  2001-04-18       Impact factor: 56.272

7.  Triggering myocardial infarction by marijuana.

Authors:  M A Mittleman; R A Lewis; M Maclure; J B Sherwood; J E Muller
Journal:  Circulation       Date:  2001-06-12       Impact factor: 29.690

8.  Tea consumption and mortality after acute myocardial infarction.

Authors:  Kenneth J Mukamal; Malcolm Maclure; James E Muller; Jane B Sherwood; Murray A Mittleman
Journal:  Circulation       Date:  2002-05-28       Impact factor: 29.690

9.  Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716.

Authors:  M A Huestis; D A Gorelick; S J Heishman; K L Preston; R A Nelson; E T Moolchan; R A Frank
Journal:  Arch Gen Psychiatry       Date:  2001-04

10.  Cannabis-induced coronary artery thrombosis and acute anterior myocardial infarction in a young man.

Authors:  Ersan Tatli; Mustafa Yilmaztepe; Gurcan Altun; Armagan Altun
Journal:  Int J Cardiol       Date:  2006-11-09       Impact factor: 4.164

View more
  47 in total

Review 1.  Triphasic blood pressure responses to cannabinoids: do we understand the mechanism?

Authors:  Barbara Malinowska; Marta Baranowska-Kuczko; Eberhard Schlicker
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 2.  Medical consequences of marijuana use: a review of current literature.

Authors:  Adam J Gordon; James W Conley; Joanne M Gordon
Journal:  Curr Psychiatry Rep       Date:  2013-12       Impact factor: 5.285

Review 3.  Risks associated with the non-medicinal use of cannabis.

Authors:  Eva Hoch; Udo Bonnet; Rainer Thomasius; Florian Ganzer; Ursula Havemann-Reinecke; Ulrich W Preuss
Journal:  Dtsch Arztebl Int       Date:  2015-04-17       Impact factor: 5.594

Review 4.  The adverse effects of cannabinoids: implications for use of medical marijuana.

Authors:  Louisa Degenhardt; Wayne D Hall
Journal:  CMAJ       Date:  2008-06-17       Impact factor: 8.262

Review 5.  [Cannabis-induced disorders].

Authors:  M Soyka; U Preuss; E Hoch
Journal:  Nervenarzt       Date:  2017-03       Impact factor: 1.214

6.  Associations Between Cannabis Use and Physical Health Problems in Early Midlife: A Longitudinal Comparison of Persistent Cannabis vs Tobacco Users.

Authors:  Madeline H Meier; Avshalom Caspi; Magdalena Cerdá; Robert J Hancox; HonaLee Harrington; Renate Houts; Richie Poulton; Sandhya Ramrakha; W Murray Thomson; Terrie E Moffitt
Journal:  JAMA Psychiatry       Date:  2016-07-01       Impact factor: 21.596

7.  No detectable association between frequency of marijuana use and health or healthcare utilization among primary care patients who screen positive for drug use.

Authors:  Daniel Fuster; Debbie M Cheng; Donald Allensworth-Davies; Tibor P Palfai; Jeffrey H Samet; Richard Saitz
Journal:  J Gen Intern Med       Date:  2013-09-19       Impact factor: 5.128

Review 8.  What is the Current Knowledge About the Cardiovascular Risk for Users of Cannabis-Based Products? A Systematic Review.

Authors:  Emilie Jouanjus; Valentin Raymond; Maryse Lapeyre-Mestre; Valérie Wolff
Journal:  Curr Atheroscler Rep       Date:  2017-06       Impact factor: 5.113

Review 9.  Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly.

Authors:  Pal Pacher; Sabine Steffens; György Haskó; Thomas H Schindler; George Kunos
Journal:  Nat Rev Cardiol       Date:  2017-09-14       Impact factor: 32.419

10.  Chest pain in young people: Is cannabis a risk factor?

Authors:  Pascal Bilbault; Corina M Duja; Jean Y Bornemann; Claire Kam; Gerald Roul; Jacques Kopferschmitt
Journal:  J Emerg Trauma Shock       Date:  2010-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.